Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial
- 1 August 1999
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 354 (9180), 716-722
- https://doi.org/10.1016/s0140-6736(99)07403-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: The ASSENT-1 trialAmerican Heart Journal, 1999
- TNK–Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial InfarctionCirculation, 1998
- Thrombolysis for Acute Myocardial InfarctionCirculation, 1998
- Equivalence TrialsNew England Journal of Medicine, 1997
- A Comparison of Reteplase with Alteplase for Acute Myocardial InfarctionNew England Journal of Medicine, 1997
- TNK-Tissue Plasminogen Activator in Acute Myocardial InfarctionCirculation, 1997
- Trials to assess equivalence: the importance of rigorous methodsBMJ, 1996
- Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial InfarctionCirculation, 1995
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparinThe Lancet, 1990